SEC Form 4 · accession 0001209191-18-020025
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Toshinari Tamura
Director
Period of report
Mar 13, 2018
Accepted (ET)
Mar 15, 2018 · 8:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2018 | M | 12,000 | $18.00 | A | 60,000 | D | |
| Common Stock | Mar 13, 2018 | M | 12,000 | $18.34 | A | 72,000 | D | |
| Common Stock | Mar 13, 2018 | S | 14,156 | $53.26 | D | 57,844 | D | |
| Common Stock | Mar 13, 2018 | S | 9,844 | $53.53 | D | 48,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.00 | Mar 13, 2018 | M | 12,000 | D | — | Nov 13, 2024 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $18.34 | Mar 13, 2018 | M | 12,000 | D | — | Jun 3, 2025 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Fully vested.